Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Proc Natl Acad Sci U S A ; 114(14): 3690-3695, 2017 04 04.
Article in English | MEDLINE | ID: mdl-28325880

ABSTRACT

Most variation in behavior has a genetic basis, but the processes determining the level of diversity at behavioral loci are largely unknown for natural populations. Expression of arginine vasopressin receptor 1a (Avpr1a) and oxytocin receptor (Oxtr) in specific regions of the brain regulates diverse social and reproductive behaviors in mammals, including humans. That these genes have important fitness consequences and that natural populations contain extensive diversity at these loci implies the action of balancing selection. In Myodes glareolus, Avpr1a and Oxtr each contain a polymorphic microsatellite locus located in their 5' regulatory region (the regulatory region-associated microsatellite, RRAM) that likely regulates gene expression. To test the hypothesis that balancing selection maintains diversity at behavioral loci, we released artificially bred females and males with different RRAM allele lengths into field enclosures that differed in population density. The length of Avpr1a and Oxtr RRAMs was associated with reproductive success, but population density and the sex interacted to determine the optimal genotype. In general, longer Avpr1a RRAMs were more beneficial for males, and shorter RRAMs were more beneficial for females; the opposite was true for Oxtr RRAMs. Moreover, Avpr1a RRAM allele length is correlated with the reproductive success of the sexes during different phases of reproduction; for males, RRAM length correlated with the numbers of newborn offspring, but for females selection was evident on the number of weaned offspring. This report of density-dependence and sexual antagonism acting on loci within the arginine vasopressin-oxytocin pathway explains how genetic diversity at Avpr1a and Oxtr could be maintained in natural populations.


Subject(s)
Arvicolinae/physiology , Microsatellite Repeats , Receptors, Oxytocin/genetics , Receptors, Vasopressin/genetics , Animals , Arvicolinae/genetics , Female , Gene Expression Regulation , Genetic Fitness , Male , Regulatory Sequences, Nucleic Acid , Reproduction
2.
Chem Biodivers ; 2(11): 1525-32, 2005 Nov.
Article in English | MEDLINE | ID: mdl-17191952

ABSTRACT

Application of molecular modeling approaches has potential to contribute to rational drug design. These approaches may be especially useful when attempting to elucidate the structural features associated with novel drug targets. In this study, molecular docking and molecular dynamics were applied to studies of inhibition of the human motor protein denoted HsEg5 and other homologues in the BimC subfamily. These proteins are essential for mitosis, so compounds that inhibit their activity may have potential as anticancer therapeutics. The discovery of a small-molecule cell-permeable inhibitor, monastrol, has stimulated research in this area. Interestingly, monastrol is reported to inhibit the human and Xenopus forms of Eg5, but not those from Drosophila and Aspergillus. In this study, homology modeling was used to generate models of the Xenopus, Drosophila, and Aspergillus homologues, using the crystal structure of the human protein in complex with monastrol as a template. A series of known inhibitors was docked into each of the homologues, and the differences in binding energies were consistent with reported experimental data. Molecular dynamics revealed significant changes in the structure of the Aspergillus homologue that may contribute to its relative insensitivity to monastrol and related compounds.


Subject(s)
Fungal Proteins/chemistry , Kinesins/chemistry , Models, Molecular , Pyrimidines/metabolism , Thiones/metabolism , Animals , Drosophila Proteins/antagonists & inhibitors , Drosophila Proteins/chemistry , Drosophila Proteins/metabolism , Fungal Proteins/antagonists & inhibitors , Fungal Proteins/metabolism , Humans , Kinesins/antagonists & inhibitors , Kinesins/metabolism , Molecular Motor Proteins/antagonists & inhibitors , Molecular Motor Proteins/chemistry , Molecular Motor Proteins/metabolism , Protein Binding/physiology , Protein Structure, Secondary/physiology , Pyrimidines/pharmacology , Thiones/pharmacology , Xenopus Proteins/antagonists & inhibitors , Xenopus Proteins/chemistry , Xenopus Proteins/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...